000 01665 a2200445 4500
005 20250515143721.0
264 0 _c20081229
008 200812s 0 0 eng d
022 _a1873-2968
024 7 _a10.1016/j.bcp.2008.09.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeurel, Eléonore
245 0 0 _aGlycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
_h[electronic resource]
260 _bBiochemical pharmacology
_cJan 2009
300 _a54-65 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAminophenols
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aCells, Cultured
650 0 4 _aDrug Synergism
650 0 4 _aGlycogen Synthase Kinase 3
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aLithium
_xpharmacology
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMaleimides
_xpharmacology
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xphysiology
650 0 4 _aTumor Cells, Cultured
700 1 _aBlivet-Van Eggelpoël, Marie-José
700 1 _aKornprobst, Michel
700 1 _aMoritz, Sylviane
700 1 _aDelelo, Roland
700 1 _aPaye, François
700 1 _aHousset, Chantal
700 1 _aDesbois-Mouthon, Christèle
773 0 _tBiochemical pharmacology
_gvol. 77
_gno. 1
_gp. 54-65
856 4 0 _uhttps://doi.org/10.1016/j.bcp.2008.09.026
_zAvailable from publisher's website
999 _c18401288
_d18401288